• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:片仔癀治疗新型冠状病毒肺炎患者SARS-CoV-2检测结果持续阳性:5例报告

Case report: Treatment with Pien-Tze-Huang for prolonged positive SARS-CoV-2 test results in COVID-19 patients: A report of five cases.

作者信息

Zheng Yujiao, Cheng Jinbo, Gu Chengjuan, Xiao Mingzhong, Shao Zuoyu, Zhao Linhua, Tong Xiaolin

机构信息

College of Traditional Chinese Medicine, Anhui University of Chinese Medicine, Hefei, China.

Xinqiao Hospital, Army Medical University, Chongqing, China.

出版信息

Front Med (Lausanne). 2022 Aug 9;9:860681. doi: 10.3389/fmed.2022.860681. eCollection 2022.

DOI:10.3389/fmed.2022.860681
PMID:36017009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9396371/
Abstract

Coronavirus disease 2019 (COVID-19) has rapidly spread around the world since December 2019, becoming a global pandemic. Atypical cases of COVID-19, manifesting as prolonged positive SARS-CoV-2 test results during the convalescence period, have been encountered. These cases increase the difficulty of COVID-19 prevention and treatment. Here, we report five cases of COVID-19 patients who demonstrated prolonged positive SARS-CoV-2 tests after regular traditional Chinese medicine and western medicine treatments. After administration of Pien-Tze-Huang and cessation of previous treatments, SARS-CoV-2 tests results of the patients turned and remained negative. We believe the finding will contribute to a better understanding of atypical COVID-19 cases and hope to offer a potential therapy. Since this is a preliminary case series, larger-scale clinical trials are warranted.

摘要

自2019年12月以来,2019冠状病毒病(COVID-19)已在全球迅速传播,成为全球大流行疾病。已发现COVID-19的非典型病例,表现为恢复期严重急性呼吸综合征冠状病毒2(SARS-CoV-2)检测结果持续呈阳性。这些病例增加了COVID-19预防和治疗的难度。在此,我们报告5例COVID-19患者,他们在接受常规中西医治疗后SARS-CoV-2检测结果持续呈阳性。在给予片仔癀并停止先前治疗后,患者的SARS-CoV-2检测结果转阴并保持阴性。我们相信这一发现将有助于更好地了解非典型COVID-19病例,并希望提供一种潜在的治疗方法。由于这是一个初步的病例系列,有必要进行更大规模的临床试验。

相似文献

1
Case report: Treatment with Pien-Tze-Huang for prolonged positive SARS-CoV-2 test results in COVID-19 patients: A report of five cases.病例报告:片仔癀治疗新型冠状病毒肺炎患者SARS-CoV-2检测结果持续阳性:5例报告
Front Med (Lausanne). 2022 Aug 9;9:860681. doi: 10.3389/fmed.2022.860681. eCollection 2022.
2
[Pneumonia due to the Chinese medicine pien tze huang].[中药片仔癀所致肺炎]
Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Jul;34(7):810-5.
3
Protective effects and potential mechanisms of Pien Tze Huang on cerebral chronic ischemia and hypertensive stroke.片仔癀对脑慢性缺血及高血压性脑卒中的保护作用及潜在机制。
Chin Med. 2010 Oct 18;5:35. doi: 10.1186/1749-8546-5-35.
4
Pien Tze Huang protects the liver against carbon tetrachloride-induced damage.片仔癀可保护肝脏免受四氯化碳诱导的损伤。
Pharmacol Toxicol. 2002 Oct;91(4):185-92. doi: 10.1034/j.1600-0773.2002.910406.x.
5
Substitution for natural musk in Pien Tze Huang does not affect its hepatoprotective activities.片仔癀中天然麝香的替代不会影响其保肝活性。
Hum Exp Toxicol. 2004 Jan;23(1):35-47. doi: 10.1191/0960327104ht414oa.
6
[Determination of saponins in Pien Tze Huang by near infrared spectroscopy].近红外光谱法测定片仔癀中的皂苷成分
Zhongguo Zhong Yao Za Zhi. 2019 Apr;44(8):1596-1600. doi: 10.19540/j.cnki.cjcmm.20190318.305.
7
Pien Tze Huang, a composite Chinese traditional herbal extract, affects survival of neuroblastoma cells.片仔癀,一种复方中国传统草药提取物,影响神经母细胞瘤细胞的存活。
Int J Neurosci. 2009;119(2):255-62. doi: 10.1080/00207450802324770.
8
[Rapid chemome characterization of Pien-Tze-Huang by DI-MS/MS~(ALL)].通过直接进样质谱/质谱联用技术对片仔癀进行快速化学组成表征~(ALL)
Zhongguo Zhong Yao Za Zhi. 2022 Jul;47(13):3501-3510. doi: 10.19540/j.cnki.cjcmm.20211025.301.
9
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
10
[Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].[用于呼吸道样本中检测严重急性呼吸综合征冠状病毒2的快速抗原检测试剂盒与聚合酶链反应的评估]
Mikrobiyol Bul. 2022 Apr;56(2):263-273. doi: 10.5578/mb.20229806.

本文引用的文献

1
Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.病例研究:一名患有癌症的无症状免疫功能低下个体长期感染性严重急性呼吸综合征冠状病毒2(SARS-CoV-2)脱落。
Cell. 2020 Dec 23;183(7):1901-1912.e9. doi: 10.1016/j.cell.2020.10.049. Epub 2020 Nov 4.
2
Positive RT-PCR Test Results in 420 Patients Recovered From COVID-19 in Wuhan: An Observational Study.武汉420例新冠肺炎康复患者的RT-PCR检测结果呈阳性:一项观察性研究。
Front Pharmacol. 2020 Oct 7;11:549117. doi: 10.3389/fphar.2020.549117. eCollection 2020.
3
Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review.新冠病毒感染治愈患者中 SARS-CoV-2 病毒 RNA 复阳:一项叙述性综述。
Eur J Clin Microbiol Infect Dis. 2021 Jan;40(1):13-25. doi: 10.1007/s10096-020-04088-z. Epub 2020 Oct 28.
4
T-cell responses and therapies against SARS-CoV-2 infection.T 细胞应答与针对 SARS-CoV-2 感染的治疗方法。
Immunology. 2021 Jan;162(1):30-43. doi: 10.1111/imm.13262. Epub 2020 Oct 27.
5
Chinese herbal medicine reduces mortality in patients with severe and critical Coronavirus disease 2019: a retrospective cohort study.中药降低重症和危重症 2019 冠状病毒病患者死亡率:一项回顾性队列研究。
Front Med. 2020 Dec;14(6):752-759. doi: 10.1007/s11684-020-0813-6. Epub 2020 Sep 14.
6
Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study.汉诗怡方(一种治疗 SARS-CoV2 感染的药物)降低了中国 COVID-19 轻症和普通型患者向重症发展的比例:一项队列研究。
Pharmacol Res. 2020 Nov;161:105127. doi: 10.1016/j.phrs.2020.105127. Epub 2020 Aug 10.
7
Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial.藿香正气滴丸和连花清瘟颗粒治疗 COVID-19 的疗效:一项随机对照试验。
Pharmacol Res. 2020 Nov;161:105126. doi: 10.1016/j.phrs.2020.105126. Epub 2020 Aug 8.
8
Rate of re-positive RT-PCR test among patients recovered from COVID-19.新冠康复患者中RT-PCR检测再次呈阳性的比率。
Biochem Med (Zagreb). 2020 Oct 15;30(3):030401. doi: 10.11613/BM.2020.030401. Epub 2020 Aug 5.
9
A systematic review of re-detectable positive virus nucleic acid among COVID-19 patients in recovery phase.关于恢复期 COVID-19 患者病毒核酸再检出阳性的系统评价。
Infect Genet Evol. 2020 Nov;85:104494. doi: 10.1016/j.meegid.2020.104494. Epub 2020 Aug 5.
10
[Analysis on formula of Mongolian medicine for prevention of COVID-19].[蒙药预防新型冠状病毒肺炎配方分析]
Zhongguo Zhong Yao Za Zhi. 2020 Jul;45(13):3013-3019. doi: 10.19540/j.cnki.cjcmm.20200425.501.